Extended indication Extension of indication to include treatment of adult patients with myelodysplastic syndromes (MDS)
Therapeutic value Possibly no place in the treatment regimen
Registration phase No registration expected

Product

Registration

Therapeutic value

Expected patient volume per year

Expected cost per patient per year

Potential total cost per year

Off label use

Indication extension

Other information